Asset Allocation

As of December 31, 2025.
Type % Net
Cash 1.17%
Stock 23.82%
Bond 71.78%
Convertible 0.00%
Preferred 2.59%
Other 0.65%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.64%    % Emerging Markets: 0.37%    % Unidentified Markets: 0.99%

Americas 94.17%
93.96%
Canada 83.32%
United States 10.64%
0.21%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.40%
United Kingdom 2.01%
2.25%
Denmark 0.00%
France 0.64%
Germany 0.01%
Ireland 0.18%
Italy 0.17%
Netherlands 0.40%
Sweden 0.81%
Switzerland 0.02%
0.14%
Poland 0.14%
0.01%
Israel 0.01%
Greater Asia 0.44%
Japan 0.32%
0.02%
Australia 0.02%
0.09%
Singapore 0.09%
0.00%
Unidentified Region 0.99%

Bond Credit Quality Exposure

AAA 27.31%
AA 14.88%
A 33.19%
BBB 15.45%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.21%
Not Available 7.96%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
13.46%
Materials
0.23%
Consumer Discretionary
3.79%
Financials
7.45%
Real Estate
1.99%
Sensitive
9.24%
Communication Services
1.07%
Energy
0.00%
Industrials
4.27%
Information Technology
3.90%
Defensive
2.76%
Consumer Staples
1.81%
Health Care
0.55%
Utilities
0.40%
Not Classified
74.54%
Non Classified Equity
0.34%
Not Classified - Non Equity
74.19%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 15.24%
Corporate 45.40%
Securitized 1.51%
Municipal 25.80%
Other 12.05%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.82%
Less than 1 Year
0.82%
Intermediate
63.74%
1 to 3 Years
12.40%
3 to 5 Years
14.81%
5 to 10 Years
36.53%
Long Term
31.36%
10 to 20 Years
12.37%
20 to 30 Years
15.66%
Over 30 Years
3.33%
Other
4.08%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial